|
| 欧洲EMAS/IGCS妇科癌症后绝经管理（关注绝经后症状及骨质疏松）立场声明解读 |
| Interpretation of the position statement of the EMAS/IGCS on managing the menopause after gynecological cancer (focusing on postmenopausal symptoms and osteoporosis) |
| |
| DOI：10.3969/j.issn.1006-7108.2021.02.030 |
| 中文关键词: 妇科癌症 卵巢功能 绝经症状 骨质疏松症 |
| 英文关键词:gynecological cancer ovarian function menopausal symptoms osteoporosis |
| 基金项目: |
|
| 摘要点击次数: 491 |
| 全文下载次数: 268 |
| 中文摘要: |
| 妇科癌症的治疗方法包括手术、放疗和化疗。这些治疗均可能导致45岁以下女性的卵巢功能丧失及提前绝经。最近，欧洲绝经与男性更年期学会(EMAS)和国际妇科癌症协会(IGCS)发布了关于妇科癌症后绝经管理的立场声明。该立场声明的目的是制订一种个体化的方案以管理妇科癌症妇女的绝经症状及防治骨质疏松症。本文就该立场声明的主要内容进行简要解读。 |
| 英文摘要: |
| Treatments methods include surgery, radiotherapy and chemotherapy for gynecological cancer. These treatments may cause loss of ovarian function and premature menopause in women under 45. Recently, the European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) issued a position statement on postmenopausal management of gynecological cancer. The aim of this position statement is to develop an individualized program to manage menopausal symptoms and prevent osteoporosis in women with gynecological cancer. This paper gives a brief interpretation of the main content of the position statement. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |